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Summary  
Nihety-nine mature New Zealand White (NZW) rabbits underwer~t unilateral anterior cruciate ligament transection 
(ACLT) and were divided into three groups. The contralateral non-operated knees served as controls. The first group 
~SA) received intra-articular injections of 0.3 ml hyaluronan (HA: MW; 8×105) beginning 4 weeks after ACLT, once 
~week for 5 weeks. The second group (SV) was injected with vehicle (carrier of HA) in the same fashion as the SA 
group. The third group (SN) served as a nontreatment group post ACLT. All animals were killed 9 weeks post-surgery 
~d were assessed by gross morphology, histomorphometry and biochemical nalysis. Gross morphologic changes on 
~he femoral cartilage in the SA group were less severe than those in the SV and SN groups. Cartilage thickness, 
cartilage area, and thickness of synovial ining cell layer histomorphometric parameters were measured, showing a 
positive ffect of HA on the preservation farticular cartilage and synovial tissue. Similarly, the cartilage and synovial 
tissues from knees injected with HA did not demonstrate significant alterations from contralateral controls as 
measured by biochemical na]ysis [i.e., water content, pyridinoline concentration, glycosaminoglycan (GAG) content 
for the cartilage, and DNA concentration for the synoviat issue]. 
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I n t roduct ion  
THERAPEUTIC treatment for osteoarthrit is (OA) 
includes medical administration of nonsteroidal 
anti-inflammatory drugs (NSAIDs) [1-5], steroids 
[6-8], physical therapy [9, 10] and surgery such as 
osteotomy and joint replacement. Oral adminis- 
tration of NSAIDs has been employed effectively; 
however long-term use of these drugs in some 
instances is accompanied with such adverse ffects 
as gastrointestinal irr itation [11, 12]. Intra- 
articular corticosteroid injections are adminis- 
tered for relief of pain in an osteoarthrit ic joint, 
but repeated injections of corticosteroids may 
induce joint destruction similar to a Charcot joint 
[13]. As a last resort, total joint replacement is
employed for advanced stage OA, especially in the 
case o f  elderly patients [14, 15]. However, this 
procedure would be contraindicated for young 
patients because of the eventual occurrence of 
prosthesis loosening [16-18]. Therefore, a safe 
chondroprotective treatment providing symp- 
tomatic relief Of joint pain is desirable. 
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Hyaluronan (HA), a high-molecular-weight 
polysaccharide, plays an important role in main- 
taining homeostasis in synovial joints. In one 
in vitro study, it was shown that HA could inhibit 
glycosaminoglycan (GAG) release from carti lage 
tissue [19]. It was also shown by Smith and Ghosh 
[20] that cultured synovial fibroblasts, derived 
from osteoarthrit ic joints, synthesized HA at an 
increased rate when extrinsic HA was added to the 
culture media. 
The aim of the present study was to evaluate the 
efficacy of administering intra-articular injections 
of hyaluronan (extracted from fresh rooster combs, 
MW = 8× 105) in maintaining the rheological and 
biochemical properties of the cartilage matrix 
during the development of OA. The animal model 
of OA, anterior cruciate l igament transection 
(ACL~T) in a rabb i t  joint, which we have 
characterized in a previous study [21] in our 
laboratory, was used for this study. 
Mater ia ls  and Methods  
EXPERIMENTAL DESIGN 
Ninety-nine New Zealand White rabbits, at least 
1 year of age with closed epiphyses, were used in 
this study. The experimental design is summarized 
in Table I. All rabbits underwent unilateral ACLT 
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and were divided into three groups of 33 rabbits 
each. The contralateral  nonoperated knees served 
as paired controls. The first group (SA) received 
0.3 ml (volume of solution that can be introduced 
without increasing joint fluid pressure) of intra- 
articular HA injections into the operated knees 4 
weeks after ACLT, once a week for 5 weeks. The 
second group (SV) was injected with vehicle 
(carrier of hyaluronan) in the same fashion as with 
the SA group. The third group (SN) underwent 
unilateral ACLT but received no injections. 
SURGICAL  PROCEDURE AND INTRA-ART ICULAR 
IN JECT ION 
All rabbits were anesthetized with an intramus- 
cular injection of ketamine (100mg/kg) and 
xylazine (8 mg/kg). Operative knees were shaved 
and disinfected with Betadine solution. A medial 
parapatel lar incision was made on the skin and a 
medial arthrotomy was performed. The patella was 
dislocated laterally and the knee placed in full 
flexion. The anterior cruciate ligament was 
visualized and transected with a # 15 blade. The 
joint capsule was then irrigated with sterile saline 
and closed with a running suture of 4-0 prolene; the 
skin incision was closed with a running mattress 
suture supplemented with interrupted sutures of 
3-0 nylon. Postoperatively the animals were 
permitted cage (60 cmx60 cmx40 cm) activity 
without immobilization. The animals were closely 
monitored for infections and other complications. 
Four weeks after surgery those rabbits receiving 
intra-articular injections of HA or vehicle were 
anesthetized with ketamine (30mg/kg) and xy- 
lazine (2 mg/kg). The ACL-transected knees were 
then shaved and disinfected with Betadine sol- 
ution. A 27-gauge needle on a tuberculin syringe 
was inserted beneath the patella in the region of 
patellofemoral joint and 0.3ml HA (1% in 
phosphate-buffered saline PBS) or vehicle (PBS) 
was injected in the intercondylar notch of the:  
femur between the medial and lateral femoral 
condyle. Intra-articular injections were performed 
once a week for 5 weeks. All animals were killed 
at 9 weeks after surgery by intracardiac injection 
of T-61 euthanasia solution. Based on the results of 
a previously published study [21] in which the 
medial femoral condyles showed the most ad- 
vanced changes following ACLT, only medial 
femoral condyles and associated synovia (entire 
tissue) were taken for analysis. 
ASSESSMENT 
All gross morphological, histological and histo- 
morphometric analyses were carried out blind. 
Gross morphology 
The femoral condyles were photographed using 
a 35-ram camera (YASHICA, Japan) equipped with 
a close-up micro lens. Gross morphological 
changes of the femoral condyles in randomly 
selected subgroups of rabbits :were assessed 
according to the criteria shown in Table II 
following the application of India ink. 
HISTOLOGICAL  PREPARATION 
The medial femoral condyles (ACLT and con- 
tralateral controls) were divided sagittally into 
two equal parts. The tissue blocks were then fixed 
in 10% neutral buffered formalin with cetylpyri- 
dinium chloride (CPC) for 7 days and decalcified 
with EDTA. CPC prevents loss of GAG from tissue 
during processing [23-25]. After decalcification 
(confirmed by X-ray), the two halves of the 
Table I 
Experimental design 
Group I (SA)* Group II (SV)t Group III$ 
Assessment ACLT-HA ACLT-Vehicle ACLT-no injection 
Gross morphology and 
histology 11 11 11 
Biochemistry 11 11 11 
Hydration 11 11 11 
Subtotal 33 33 33 
Total number of rabbits 99 
*HA (0.3 ml) (1% solution of hyaluronan) injected 4 weeks after ACLT, once 
a week x 5 weeks, killed at 9 weeks after ACL transection. 
tVehicle (0.3 ml) (carrier of hyaluronan) injected 4 weeks after ACLT, once a 
week x 5 weeks, killed at 9 weeks after ACL transection. 
SAnterior cruciate ligament transected, killed at 9 weeks after ACL 
transection. 
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Table II 
Gross morphological assessment 
• Grade 1: (Intact surface) Surface normal in appearance and does not 
retain India ink. 
• Grade 2: (Minimal fibrillation) Surface retains the India ink as elongated 
specks or light gray patches. 
• Grade 3: (Overt fibrillation) Areas which are velvety in appearance and 
retain ink as intense black patches. 
• Grade 4: (Erosion) Loss of cartilage xposing the underlying bone 
Grade 4a: 0 mm < Erosion _< 2 mm 
Grade 4b: 2 mm < Erosion _< 5 mm 
Grade 4c: 5 mm < Erosion 
condyles were embedded in paraffin. Five micron 
sections (three from each half) were cut with a 
Reichert- Jung microtome and stained with 
Safranin O/fast green. Synovium from ACLT knees 
and contralateral  controls from each group were 
also processed, embedded in paraffin and stained 
with hematoxylin and eosin (H&E) for cellular 
assessment by image analysis. 
HISTOMORPHOMETRY 
Six Safranin O-stained sections from each 
medial condyle were assessed and averaged using 
a color image analysis system (Oncor instrument 
systems, U.S.A.). Histologic sections were visual- 
ized with a microscope (Nikon Microphot, 
Japan) and an attached high-resolution color 
video camera (Hitachi HV-C10, Japan). Video 
images were captured by high-definition video 
processing boards of the image analysis system 
within the microcomputer (Everex 486/25, 
U.S.A.). Processed images were viewed on a 
• high-resolution color monitor (Sony Trinitron, 
Japan). 
Customized software was developed to measure 
carti lage thickness, carti lage area, surface rough- 
ness of  cartilage, and thickness of the synovial 
lining cell layer [21, 26]. A 7 mm weight-bearing 
section of the femoral condyle (taken from the 
region of greatest carti lage damage) was defined 
and analyzed (Fig. 1). The thickness of cart i lage 
from the surface to the tide mark was calculated 
from the mean of five measurements made 
perpendicular to the surface of each section at 
five equally spaced points along the 7 mm length. 
The area of the carti lage present between the 
monitor screen edges (7 mm) was likewise calcu- 
lated. The thickness and area of cartilage were 
computed using a mathematical algorithm with 
the co-ordinate of art icular cartilage and tide 
mark. 
The surface profile of each specimen was 
assessed by determining the surface roughness 
[26]. Calculation of carti lage roughness is based 
on the deviations from an idealized smooth 
surface which is derived from shape parameters 
of normal carti lage outside of the region of 
degeneration. This parameter is expressed as 
the root mean square (RMS) surface roughness 
calculated from the following equation: 
Control ACLT 
SV 
SN 
~Grade2 ~Grade3 Grade4a ~Grade4b~Grade4c  
FIG. 1. Gross morphological ssessment ofmedial femoral condyles from SA, SV and SN groups; N= 11 for each group. 
Note that the grade of cartilage damage in the SA group was generally less severe than in the SV and SN groups. 
[ __  r I _ _ ± _ _ J  [ _ _  p__  I .... - , _ _4  
0 50 100% 0 50 100% 
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254 Yosh ioka  et  al.: HA ef fec t  on  a mode l  o f  OA 
RMS surface roughness 
=(N i~ (Yidealizedi - Yreali)2tl/2 
where N is the number of digitized points; 
Yidealizedi is the theoretical coordinate of the 
idealized smooth surface of articular cartilage 
determined from the coordinates of the subchon- 
dral bone and mean thickness of the cartilage 
region; and Yreali is the actual coordinate of the 
articular cartilage surface. 
Surface roughness is, in part, dependent on 
surface thickness, i.e., a thicker cartilage surface 
is more susceptible to variations in wear, which in 
turn produces a larger surface roughness measure- 
ment. Conversely, a joint surface completely 
denuded of cartilage would yield a falsely-low 
surface roughness measurement. Therefore, a more 
meaningful calculation of surface roughness 
normalized to cartilage thickness was made: 
normalized cartilage roughness equals the RMS 
roughness/cartilage thickness. All roughness data 
is presented using this calculation. 
Synovial tissues were assessed by measuring the 
thickness of the synovial lining cell layer. This 
thickness was determined by averaging the 
measured thickness at 100 different locations 
along the length of the histological (H&E) section 
of synovium dissected from the infrapatellar region 
of the knee. 
Biochemistry 
Hydration study. Articular cartilage obtained from 
the medial femoral condyles of contralateral 
control and ACLT knees, taking care to avoid 
bone. The tissue was immediately placed into 
pre-weighed vials. Each specimen and vial was 
weighed to an accuracy of 0.1 mg. After weighing, 
the samples were lyophilized. The vials and 
samples were weighed again, and the amount of 
hydration was calculated. 
Non-reducible collagen cross-links (pyridinoline) 
concentration. The concentration of the nonre- 
ducible collagen cross-link (hydroxypyridinium) 
contained in articular cartilage from the medial 
condyles (ACLT and contralateral control) was 
determined by reversed-phase high-performance 
liquid chromatography (HPLC). Five milligrams 
(dry) of tissue was hydrolyzed in 6 N HC1 overnight 
at 108°C. After desiccation, the hydrolysate was 
redissolved in 1% heptafluorobutyric acid and the 
cross-link hydroxypyridinium was isolated on a 
reversed-phase column (ODS, C-18; Beckman 
Instruments U.S.A.). Elution was by a gradient of 
acetonitrite (12-18%) in 0.01 M heptafluorobutyric 
acid. Monitoring and quantitation of hydroxypyri- 
dinium was achieved by in-line fluorescence 
(ex. = 297 nm, em = 390 nm). The standard employed 
was pyridoxamine, which has identical spectral 
characteristics with hydroxypyridinium. An all- 
quot of the hydrolysate was sampled for determi- 
nation of hydroxyprotine content [27]. A 
conve~csion factor of 7.46×hyp was used to 
calculate the amount of Collagen. Results are 
expressed as equivalent moles of pyridoxamine per 
mole of collagen. 
GAG content. Amounts of total GAG content in the 
medial condyle cartilage were determined on the 
basis of total hexosamine (amino sugar) concen- 
tration [27]. Three to 5 mg of lyophilized cartilage 
were hydrolyzed in 1 ml O f 6 N HC1 for 5 h at 100°C 
in a boiling water-bath. The acid hydrolysates were 
desiccated and treated ~ccording to the Boas 
procedure. Hexosamine quantitation was achieved 
by a modified Elson-Morgan reaction. Results are 
expressed as micrograms of amino sugar per 
milligram of dry tissue. 
DNA concentration (tissue cellularity). Relative 
cellularity in synovial tissue was assessed by 
quantitating the tissue concentration of DNA 
according to the procedure of Bonting and Jones, 
as modified by Amiel et al. [27]. Seven to 10 mg of 
water washed and lyophilized synovial tissue were 
solubilized by incubation for 2 h in 3.0 ml of 1 N 
NaOH at 65°C. Duplicate 1.0ml aliquots were 
reacted with 0.04% indole-HC1 reagent and 
extracted with chloroform to remove interfering 
substances. The aqueous phase containing the 
DNA was removed and the absorbency was read at 
490 nm. Standards of calf thymus DNA were also 
determined for comparison. Results are expressed 
as micrograms of DNA per milligram of dry tissue. 
STATISTICAL ANALYSIS 
To establish differences between ACLT and 
contralateral control a two-tailed t-test using 
paired sets of data was employed. In this analysis, 
the data were explicitly screened for normality 
justifying use of the parametric t-test. To evaluate 
differences in ACLT data between treatment 
groups (i.e., SA, SV and SN), analyses of variance 
using unpaired ata sets were employed. The level 
of significance for each type of analysis was set at 
0.05. 
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Resu l ts  
GROSS MORPHOLOGICAL ASSESSMENT 
From surgery to death neither postoperative 
infections nor adverse reactions to HA or the 
vehicle injections were observed. Three rabbits 
died from unknown causes 5 weeks after surgery. 
All specimens from the ACLT knees exhibited 
complete transection of the ACL at sacrifice. Gross 
fibrotic thickening of the joint capsule was 
observed, as well as a brown colored synovial 
hypertrophy around the anterior cruciate ligament 
in the ACL transected knees. 
Femoral condyle; ACLT  knee 
One of 11 ACLT condyles from the SA 
(hyaluronan injected) group showed an intact 
articular cartilage surface. Six of 11 condyles from 
the SV (vehicle injected) group and six of 11 from 
the SN (no injection) group developed Grade 4 
damage. Four of 11 condyles from the SA group 
also showed full-thickness ulceration of the 
articular cartilage; however the extent and grade 
of cartilage damage in the SA cartilage was 
generally less severe than in the SV and SN groups 
(Fig. 1). Full-thickness ulceration was seen in 44% 
of the medial condyles, and only 2% of the lateral 
condyles. 
Osteophytes were seen along the ridge of the 
patellofemoral joint even in the specimens with 
intact cartilage surfaces. Occasionally these 
osteophytes extended to the femorotibial joint. 
Osteophytes in the SV and SN groups were 
generally more extensive than in the SA group. 
HISTOLOGY- -QUAL ITAT IVE  OBSERVATIONS 
Femoral condyle 
Varying degrees of histological evidence of 
degenerative changes were observed in the ACLT 
knees. Three specimens in the SA group exhibited 
normal appearing cartilage surfaces, i.e., normal 
Safranin-O staining. Full-thickness ulcerations of 
the cartilage xposing the surface of the subchon- 
dral bone were seen in all groups; however the 
extent of ulceration in the cartilage from the SA 
group was less when compared with the SV and SN 
groups. Extensive loss of Safranin-O staining was 
seen in the fibrillated areas of OA cartilage in all 
groups, especially the SN group [Fig. 2(a)-(d)]. 
Synovium 
Histologically, synovium from the intra-patellar 
fat pads of the ACLT knees from all groups 
exhibited hyperplasia of the cells in the synovial 
lining with a mononuclear cell infi ltration [Fig. 
3(a)-(d)]. 
HISTOMORPHOMETRY- -QUANTITAT IVE  ANALYSIS  
Cartilage thickness and area 
Decreases in cartilage thickness and area in the 
SV and SN groups were statistically significant 
(P < 0.05) when compared with their contralateral 
knees, however, no statistically-significant differ- 
ences were detected in cartilage thickness and 
area between the ACLT and control knees in the 
SA group (Fig. 4 and 5). 
Femoral condyle; contralateral control 
With the exception of two specimens, articular 
cartilage from the femoral condyles of the 
contralateral control knees were free from evi- 
dence of osteoarthritis, in those specimens that did 
show some evidence of OA, the changes were mild 
(Grade 2). 
Surface roughness 
Normalized surface roughness values of the 
ACLT cartilage from the SV and SN groups were 
significantly greater (P < 0.05) than their respect- 
ive contralateral controls. However, normalized 
surface roughness of the ACLT cartilage from the 
SA group was not statistically different han its 
contralateral control (Fig. 6). 
Synovium 
Synovial hypertrophy with brown coloration 
was observed in the ACLT knees. Generally, 
specimens in thereSA group showed lesser hyper- 
trophic changes than in the SV and SN groups. The 
synovium from contralateral knees showed ~no 
evidence of hypertrophy. 
Thickness of synovial ining cell layer 
All specimens f rom the ACLT knees showed 
thickening of the cell layer in the synovial ining 
(P < 0.05 for each group). The cell layers in the 
synovia from the SV and SN groups were 
approximately twice as thick as their respective 
contralateral controls (Fig. 7), while in the SA 
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FIG. 2. Histology (Safranin O/fast green) of the femoral con~ . group 
(original magnification ×30). Cartilage fibrillation and loss of Safranin b staining is seen. (b) A: ~pical ACLT 
specimen from the SV group (original magnification ×30). A marked decrease in cartilage thickness is seen, along 
with fibrillation and lower intensity of Safranin O staining. (c) A typical ACLT specimen from the SN group 
(original magnification ×30). Ulceration of the cartilage xposing the smooth surface of the subchondral bone is 
seen, along with severe loss of Safranin O staining. (d) Contralateral control specimen (original magnification x30). 
Cartilage matrix is consistently well stained with safranin O while cartilage thickness and smoothness is 
maintained. 
group this thickness was about  1.5 times con- 
trol. When compar ing the synovium from the 
SA group to the synovium from the SV and 
SN groups, respectively,  less th ickening was 
seen in the SA group (P < 0.05 for each compari- 
son). 
BIOCHEMISTRY 
Hydration study 
The water  content  of medial  femoral  condyle 
cart i lage from the ACLT knees in the SV and SN 
groups was stat ist ical ly h igher than in control  
carti lage. ACLT cart i lage from the SA group 
exhibited no stat ist ical ly-signif icant difference in 
water  content  from contra latera l  control  cart i lage 
(Fig. 8). 
Non-reducible collagen cross-links 
(h ydroxypyridinium) 
The concentrat ion  of hydroxypyr id in ium in the 
medial femoral  condyle cart i lage from the ACLT 
knees in the SV and SN group was: statist ical ly 
decreased (P<0.05)  relat ive to  contra latera l  
control  carti lage. No statist ical ly-signif icant 
differences, however,  were found between the 
ACLT and control  cart i lage in the SA group. These 
results are i l lustrated in Fig. 9. 
GAG content 
GAG concentrat ion  in the femoral  condyle 
cart i lage from the ACLT knees of the SV and SN 
groups was signif icantly lower (P < 0.05) when 
compared with contra latera l  controls. No statisti- 
cal difference between ACLT and contro l  cart i lage 
was demonstrated in the SA group (Fig. 10). 
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FIG. 3. Histology (H&E) of synovium (a) ACLT knee specimen from the SA group (original magnification x93). 
Hyperplasia of synovial ining cell layer is moderate (arrow). (b) ACLT knee specimen from the SV group (original 
magnification x93). Hyperplasia of synovial lining cells is marked (arrow). (c) ACLT knee specimen from the SN group 
(original magnification x93). Along with the hyperplasia of synovial ining cell layer (arrow), vascular formation (black 
arrow) is seen. (d) Contralateral control knee specimen (original magnification ×93). Proliferation of the synovial ining 
cell layer is minimal (arrow). 
DNA concentration in synovium 
DNA concent ra t ion  was s igni f icant ly  h igher  in 
the synov ium from the ACLT knees of the SV and 
SN groups than  in the synov ium from the 
cont ra la tera l  contro l  knees (P < 0.05). In contrast ,  
there was no s igni f icant dif ference in DNA 
concent ra t ion  between exper imenta l  and contro l  
synov ium in the SA group. Results  are shown in 
Fig. 11. 
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FIG. 4. Cartilage thickness in medial femoral condyle 
cartilage (mean ± S.D.): N-- 11 for each group; *P < 0.05, 
contratateral control vs ACLT. ([]) ACLT; ( I )  control. 
1 
2 
SA SV SN 
FIG. 5. Cartilage area in medial femoral ~condyle 
cartilage (mean ± S.D.): N= 11 for each group; *P < 0.05, 
contralateral control vs ACLT. ([]) ACLT; ( I )  control. 
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FIG. 6. Normalized cartilage roughness (RMS roughness 
divided by cartilage thickness) of the femoral condyles 
(mean _+ S.D.): N= 11 for each ACLT group; *P < 0.05, 
contralateral control vs ACLT. (Ea) ACLT; ( I )  control. 
Discuss ion  
The results of the present study demonstrate he 
therapeutic effects of HA on experimentally 
induced OA. Under pathological conditions uch 
as OA and rheumatoid arthritis, the intrinsic 
concentration and molecular weight of HA are 
lower than in the normal joint [28]. It is of interest 
that HA, having a molecular weight that is 
relatively low compared with that found in normal 
synovial fluid (8 x 10 ~ vs 4-5 x 10G), demonstrated a 
protective effect on articular cartilage in the 
experimental OA model used in the present study. 
Other studies have shown that in the initial 
stages after injection of exogenous HA, the HA in 
the synovial fluid decreases in molecular weight, 
and in later stages, the molecular weight of HA in 
the synovial fluid increases to a value greater than 
the original before the injection [29]. This 
phenomenon has been explained by the theory that 
30 
2O 
o9 
SA sv 
/ 
SN 
] 
FIG. 7. Thickness of the synovial lining cell layer 
(mean_ S.D.): N=11 for each group; *P< 0.05, con- 
tralateral control vs ACLT. SA ACLT vs SV ACLT: 
P < 0.05. SA ACLT vs SN ACLT: P < 0.05. ([]) ACLT; 
( I )  control. 
1°° I 
FIG. 
75 
50 
25 l/ 
SA SV SN 
8. Water content in medial femoral condyle 
cartilage (mean _+ S.D.): N= 11 for each group; *P < 0.05, 
contralateral control vs ACLT. ([]) ACLT; ( I )  control. 
exogenous HA stimulates the production of 
endogenous HA by positive feedback [30]. 
An important result from the present study was 
the partial suppression of synovia~hyperplasia by 
HA following induction of OA. in  a positive 
feedback mechanism, exogenous HA might induce 
synovial cells (Type B) to synthesize ndogenous 
HA of a higher molecular weight, thereby 
decreasing the synovial inflammatory response to 
ACLT. Such an increase in endogenous HA 
production might then reduce pathogenesis of the 
intra-articular environment and help maintain 
joint homeostasis. In addition to the proposed 
direct feedback mechanism, Cardarelli et al. [31] 
demonstrated that exogenous HA added to inflam- 
matory synovial fluid was able to restore the 
scavenger properties associated with normal 
synovial fluid. 
Evidence of art icular cartilage degeneration 
includes the appearance of abnormal histomorpho- 
metric properties such as increased surface 
0.8~ 
o 0.6 
~3 0.4 
o9 
0.2 
o 
0 
SA SV SN 
Fro. 9. Pyridinoline concentration i medial femoral 
condyle cartilage (mean ± S.D.): N= 11 for each group; 
*P < 0.05, contralateral control vs ACLT. (g~) ACLT; 
( . )  control. 
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FIG. !0. GAG content in medial femoral condyle 
cartilage (mean _+ S.D.): N= 11 for each group; *P < 0.05, 
contralateral control vs ACLT. (~3) ACLT; (m) control. 
roughness, cleft formation, and loss of specific 
matrix components, i.e. proteoglycans and hydrox- 
ypyridinium collagen cross-links. Fissures in the 
cartilage would likely enable proteoglycans to be 
more easily released from the tissue matrix while 
inflamed synovium might result in increased 
synthesis of proteases leading to collagen break- 
down, i.e. decreased pyridinoline cross-links. 
Development of OA, accompanied with art icular 
cartilage degeneration, has been shown to be 
coincident with an increase in the secretion of 
prostaglandin E2 PGE2 by synovial cells after 
activation by IL-I~. Affecting this relationship, HA 
has been shown to suppress ynovial cell release of 
PGE2 secondary to IL-I~ activation [32]. The 
involvement of metalloproteinases in the loss of 
cartilage matrix during the development ofOA has 
also been established [33]. In a related study it was 
shown that HA reduced the stromelysin: tissue 
inhibitors of metalloproteinase-1 (TIMP-1) ratio in 
bovine Chondrocytes, uggesting that HA contrib- 
utes a protective component in suppression of 
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SA SV SN 
FIG. 11. DNA concentration i synovium from medial 
femoral condyle (mean + S.D.): N= 11 for each group; 
*P < 0.05, contralateral control vs ACLT. (~]) ACLT; 
( I )  control. 
cartilage matrix degeneration byincreasing TIMP 
1 production [34]. 
In the present study, normalized surface rough- 
ness was shown to be less severe in carti lage from 
the HA-treated group than in carti lage from the 
vehicle-treated or untreated groups, while synovial 
hyperplasia was mitigated. Biochemical analysis 
demonstrated that the concentrations of GAGs and 
hydroxypyridinium in carti lage of the HA-injected 
knees were not statistically different han in the 
cartilage from contralateral  controls. These data 
suggest that HA inhibited the loss of both 
proteoglycans and pyridinoline cross-links from 
osteoarthrit ic art icular cartilage. 
The present study has quantitatively examined 
important histomorphometric and biochemical 
parameters which determine the integrity of 
art icular cartilage matrix. Despite uncertainty 
regarding exact mechanisms, the data generated in
this study has demonstrated that exogenously 
administered HA has a positive effect on the 
maintenance of cartilage matrix integrity during 
the development of osteoarthrit is following ACL 
transection. 
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